Secondary Logo

Journal Logo

Articles by Edward Abraham

The Role of Leptin in the Development of Pulmonary Neutrophilia in Infection and Acute Lung Injury*

Ubags, Niki D.; Vernooy, Juanita H.; Burg, Elianne; More

Critical Care Medicine. 42(2):e143-e151, February 2014.

Outcome measures for clinical research in sepsis: A report of the 2nd Cambridge Colloquium of the International Sepsis Forum

Marshall, John C.; Vincent, Jean-Louis; Guyatt, Gordon; More

Critical Care Medicine. 33(8):1708-1716, August 2005.

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial*

Opal, Steven; Laterre, Pierre-Francois; Abraham, Edward; More

Critical Care Medicine. 32(2):332-341, February 2004.

Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial*

Schuster, Daniel P.; Metzler, Michael; Opal, Steven; More

Critical Care Medicine. 31(6):1612-1619, June 2003.

Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure

Abraham, Edward; Naum, Chris; Bandi, Venkata; More

Critical Care Medicine. 31(3):718-728, March 2003.

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study

Abraham, Edward; Reinhart, Konrad; Svoboda, Petr; More

Critical Care Medicine. 29(11):2081-2089, November 2001.

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients

Abraham, Edward; Laterre, Pierre-François; Garbino, Jorge; More

Critical Care Medicine. 29(3):503-510, March 2001.

Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation

Abraham, Edward; Matthay, Michael A.; Dinarello, Charles A.; More

Critical Care Medicine. 28(1):232-235, January 2000.

Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndromeA controlled, randomized, double-blind, multicenter clinical trial

Abraham, Edward; Baughman, Robert; Fletcher, Eugene; More

Critical Care Medicine. 27(8):1478-1485, August 1999.

Confirmatory interleukin-1 receptor antagonist trial in severe sepsisA phase III, randomized, doubleblind, placebo-controlled, multicenter trial

Opal, Steven M.; Fisher, Charles J.; Dhainaut, Jean-Francois A.; More

Critical Care Medicine. 25(7):1115-1124, July 1997.